This decision follows the recent stockholder approval of Aerovate’s merger with Jade Biosciences, Inc. The reverse split is scheduled in anticipation of the merger’s completion, with the ...

Aerovate Therapeutics, Inc. (NASDAQ:AVTE), currently trading at $2.75, announced on Monday that its board of directors has approved a 1-for-35 reverse stock split. This decision follows the recent ...

There are problems integrating different workplace cultures. Regulatory issues complicate the merger timeline. Management power struggles hamper productivity. Additional debt or unforeseen ...

Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics.

Showcase your company news with guaranteed exposure both in print and online Gather your employees for an afternoon of games as we honor the Best Places to… Network with our region's hottest ...

The Federal Reserve's board approved the deal on Friday, April 18. The merger brings together two of the country's top credit card issuers, giving Capital One control of Discover's global payments ...